BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 17184862)

  • 21. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of drug intermediates by using direct organocatalytic multi-component reactions.
    Ramachary DB; Kishor M; Reddy GB
    Org Biomol Chem; 2006 May; 4(9):1641-6. PubMed ID: 16633553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early chemical development at Legacy Wyeth Research.
    O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K
    Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of biotransformations and biocatalysis to complexity generation in organic synthesis.
    Hudlicky T; Reed JW
    Chem Soc Rev; 2009 Nov; 38(11):3117-32. PubMed ID: 19847346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Industrial biocatalysis.
    Zaks A
    Curr Opin Chem Biol; 2001 Apr; 5(2):130-6. PubMed ID: 11282338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical synthesis in microreactors.
    Watts P; Haswell SJ
    Methods Mol Biol; 2010; 583():109-20. PubMed ID: 19763461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 31. A 'Fine' chemical industry for life science products: green solutions to chemical challenges.
    Bruggink A; Straathof AJ; van der Wielen LA
    Adv Biochem Eng Biotechnol; 2003; 80():69-113. PubMed ID: 12747542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated approach to developing chemoenzymatic processes at the industrial scale.
    Tao J; Zhao L
    Ernst Schering Found Symp Proc; 2006; (3):117-31. PubMed ID: 17695713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly engineered biocatalysts for efficient small molecule pharmaceutical synthesis.
    Lalonde J
    Curr Opin Biotechnol; 2016 Dec; 42():152-158. PubMed ID: 27261887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocatalysis in drug discovery and development.
    Fryszkowska A; Devine PN
    Curr Opin Chem Biol; 2020 Apr; 55():151-160. PubMed ID: 32169795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 39. Asymmetric processes in the large-scale preparation of chiral drug candidates.
    O'Brien MK; Vanasse B
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):793-806. PubMed ID: 19649907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocatalytic routes to chiral amines and amino acids.
    Gotor-Fernández V; Gotor V
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.